ber den Einflu von o,p-DDD [2,2-bis(2-chlorphenyl-4-chlorphenyl)-1,1-Dichlor than] auf die Steroidausscheidung im Harn bei Nebennieren-Gesunden und bei einigen F llen typischer adrenocorticaler Funktionsst rung

This publication has 23 references indexed in Scilit:

• EFFECT OF o,p′DDD IN A PATIENT WITH CUSHING'S SYNDROME*
  Journal of Clinical Endocrinology & Metabolism, 1961
• CHEMOTHERAPY OF ADRENOCORTICAL CANCER WITH o,p′DDD
  Annals of Internal Medicine, 1960
• Regression of Adrenal Cancer and Suppression of Adrenal Function in Man by o,p′-DDD
  Published by Elsevier ,1960
• EFFECTS OF o,p' DDD¹ON HISTOLOGY AND 17- HYDROXYCORTICOSTEROID OUTPUT OF THE DOG ADRENAL CORTEX¹
  Endocrinology, 1959
• ACTION OF AN ADRENOCORTICOLYTIC DRUG IN MAN
  The Lancet, 1959
• BIOLOGICAL STUDIES ON AN ADRENOCORTICOLYTIC AGENT AND THE ISOLATION OF THE ACTIVE COMPONENTS¹²³
  Endocrinology, 1958
• THE CHEMICAL FRACTIONATION OF AN ADRENOCORTICOLYTIC DRUG¹²³
  Endocrinology, 1958
• Administration of DDD (2,2-bis (Parachlorophenyl)-1,1-Dichloroethane) to Diabetics with Hyaline Vascular Changes and Hyperpolysaccharidemia
  Acta Medica Scandinavica, 1956
• EFFECT OF HYPOPHYSECTOMY, DDD TREATMENT, AND SURGICAL TRAUMA ON THE OXYGEN CONSUMPTION OF THE VARIOUS ZONES OF THE ADRENAL CORTEX1
  Endocrinology, 1953
• D.D.D. THERAPY IN CUSHING'S SYNDROME
  The Lancet, 1953